SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 294.16 |
Enterprise Value ($M) | 310.82 |
Book Value ($M) | 81.92 |
Book Value / Share | 6.85 |
Price / Book | 3.59 |
NCAV ($M) | -13.75 |
NCAV / Share | -1.15 |
Price / NCAV | -21.39 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.07 |
Return on Assets (ROA) | -0.06 |
Return on Equity (ROE) | -0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.15 |
Current Ratio | 5.15 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 125.60 |
Assets | 221.28 |
Liabilities | 139.36 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 28.49 |
Operating Income | -39.98 |
Net Income | -13.82 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.75 |
Cash from Investing | -28.26 |
Cash from Financing | -11.13 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | Biotechnology Value Fund L P | 25.30 | -17.91 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,226 | 13,085 | 17.01 | |
4,274 | 20,332 | 21.02 | |
3,248 | 13,430 | 24.18 | |
2,018 | 14,219 | 14.19 | |
(click for more detail) |
Similar Companies | |
---|---|
WVE – Wave Life Sciences Ltd. | XENE – Xenon Pharmaceuticals Inc. |
XNCR – Xencor, Inc. |
Financial data and stock pages provided by
Fintel.io